Doctor James Rucker

Dr James Rucker is an NIHR (National Institute for Health and Care Research) Clinician Scientist. He qualified in medicine at University College, London in 2003 before joining The South London & Maudsley rotational training scheme as a junior psychiatric trainee in 2005. Doctor Rucker attained membership of the Royal College of Psychiatrics in 2007 before completing a PhD in molecular genetics in 2012. He completed his higher psychiatric training in general adult and old age psychiatry at Springfield and St George’s Hospital between 2014 and 2018. He leads the Psychoactive Trials Group at the Centre for Affective Disorders, specialising in mood disorders in adults, novel psychopharmacological approaches for those suffering treatment-resistant depression and related conditions, clinical trials in drug assisted forms of psychotherapy and the use of psilocybin, MDMA, ketamine and cannabinoids to treat mental health conditions.

Doctor James Rucker has also written in:


PhD Molecular Genetics, King’s College London 2012 | Bachelor of Medicine, University College London 2003 | Bachelor of Science, Human Physiology & Basic Medical Sciences, University College London 2000.

Consultant in General Adult & Old Age Psychiatry Doctor of Philosophy, MRCPsych.


He currently holds a 5-year Clinician Scientist Fellowship awarded by the National Institute for Health Research to investigate psilocybin as a treatment for major depressive disorder that has proven resistant to standard treatments.


ASCP Annual Meeting New Investor Award – March 2020, NIHR Clinician Scientist Fellowship – November 2017.

Previous Experience:

Dr Rucker has over 15 years experience as a psychiatrist and 10 years experience as a clinical academic. During this time he has gained experience in the assessment and treatment of a wide array of mental health conditions, published numerous peer reviewed articles in the field and is both principle and chief investigator on numerous clinical trials for new treatments in psychiatry. He has extensive experience of engaging with new and emerging biotech companies as well as established pharmaceutical companies. He practices clinically at the NHS National and Specialist Mood Disorders Service at the Maudsley Hospital in South London, as well as seeing private patients.

top articles by Doctor James Rucker

Is CBD Effective for Arthritis and Joint Pain?

13th September 2022

Cannabis-Based Medicinal Products: Understanding the Current Evidence

7th September 2022

Understanding the Risks for Medical Cannabis Patients

2nd September 2022

other authors